Debananda Das

2.5k total citations
45 papers, 1.7k citations indexed

About

Debananda Das is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Debananda Das has authored 45 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 34 papers in Virology and 13 papers in Epidemiology. Recurrent topics in Debananda Das's work include HIV/AIDS drug development and treatment (35 papers), HIV Research and Treatment (34 papers) and HIV/AIDS Research and Interventions (12 papers). Debananda Das is often cited by papers focused on HIV/AIDS drug development and treatment (35 papers), HIV Research and Treatment (34 papers) and HIV/AIDS Research and Interventions (12 papers). Debananda Das collaborates with scholars based in United States, Japan and India. Debananda Das's co-authors include Hiroaki Mitsuya, Arun K. Ghosh, Kenji Maeda, Yasuhiro Koh, Masayuki Amano, Manabu Aoki, Yasushi Tojo, Hirotomo Nakata, Hironori Hayashi and David A. Davis and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Chemical Physics.

In The Last Decade

Debananda Das

44 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Debananda Das United States	25	1.0k	920	489	299	263	45	1.7k
Joseph D. Bauman United States	21	894 0.9×	724 0.8×	840 1.7×	389 1.3×	258 1.0×	32	1.7k
Mingjun Huang United States	17	436 0.4×	392 0.4×	409 0.8×	167 0.6×	438 1.7×	59	1.6k
K. E. B. PARKES United Kingdom	15	640 0.6×	513 0.6×	632 1.3×	204 0.7×	400 1.5×	32	1.4k
Masayuki Amano Japan	24	946 0.9×	736 0.8×	313 0.6×	274 0.9×	465 1.8×	72	1.5k
William E. Kohlbrenner United States	19	924 0.9×	695 0.8×	774 1.6×	353 1.2×	521 2.0×	34	1.9k
Eric Deprez France	27	1.1k 1.1×	1.1k 1.2×	1.3k 2.7×	191 0.6×	159 0.6×	68	2.2k
Derek Kinchington United Kingdom	17	954 0.9×	726 0.8×	589 1.2×	307 1.0×	325 1.2×	41	1.5k
B. Govinda Rao United States	18	716 0.7×	339 0.4×	564 1.2×	510 1.7×	252 1.0×	38	1.7k
Roger D. Tung United States	24	657 0.6×	451 0.5×	773 1.6×	191 0.6×	468 1.8×	41	2.0k
Michael Caffrey United States	29	494 0.5×	297 0.3×	1.2k 2.4×	511 1.7×	115 0.4×	94	2.1k

Countries citing papers authored by Debananda Das

Since Specialization

Citations

This map shows the geographic impact of Debananda Das's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Debananda Das with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Debananda Das more than expected).

Fields of papers citing papers by Debananda Das

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Debananda Das. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Debananda Das. The network helps show where Debananda Das may publish in the future.

Co-authorship network of co-authors of Debananda Das

This figure shows the co-authorship network connecting the top 25 collaborators of Debananda Das. A scholar is included among the top collaborators of Debananda Das based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Debananda Das. Debananda Das is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Das, Debananda. (2024). HIV-1 protease inhibitors and mechanisms of HIV-1's resistance. Global Health & Medicine. 6(6). 357–362.

Kumamoto, Hiroki, Nobuyo Higashi‐Kuwata, Sanae Hayashi, et al.. (2023). Synthesis of novel entecavir analogues having 4′-cyano-6′′-fluoromethylenecyclopentene skeletons as an aglycone moiety as highly potent and long-acting anti-hepatitis B virus agent. RSC Advances. 13(23). 15999–16011. 2 indexed citations

Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Hiroki Kumamoto, et al.. (2020). Identification of a novel long-acting 4’-modified nucleoside reverse transcriptase inhibitor against HBV. Journal of Hepatology. 74(5). 1075–1086. 21 indexed citations

Hayashi, Sanae, Nobuyo Higashi‐Kuwata, Debananda Das, et al.. (2020). 7-Deaza-7-fluoro modification confers on 4′-cyano-nucleosides potent activity against entecavir/adefovir-resistant HBV variants and favorable safety. Antiviral Research. 176. 104744–104744. 3 indexed citations

Bulut, Haydar, Shin‐ichiro Hattori, Hironori Hayashi, et al.. (2020). Single atom changes in newly synthesized HIV protease inhibitors reveal structural basis for extreme affinity, high genetic barrier, and adaptation to the HIV protease plasticity. Scientific Reports. 10(1). 10664–10664. 70 indexed citations

Higashi‐Kuwata, Nobuyo, Sanae Hayashi, Debananda Das, et al.. (2019). CMCdG, a Novel Nucleoside Analog with Favorable Safety Features, Exerts Potent Activity against Wild-Type and Entecavir-Resistant Hepatitis B Virus. Antimicrobial Agents and Chemotherapy. 63(4). 15 indexed citations

Kumamoto, Hiroki, Manabu Aoki, Masayuki Amano, et al.. (2019). Synthesis and evaluation of the anti-hepatitis B virus activity of 4′-Azido-thymidine analogs and 4′-Azido-2′-deoxy-5-methylcytidine analogs: structural insights for the development of a novel anti-HBV agent. Nucleosides Nucleotides & Nucleic Acids. 39(4). 518–529. 1 indexed citations

Nakata, Hirotomo, Kenji Maeda, Debananda Das, et al.. (2019). Activity and structural analysis of GRL-117C: a novel small molecule CCR5 inhibitor active against R5-tropic HIV-1s. Scientific Reports. 9(1). 4828–4828. 7 indexed citations

Takamatsu, Yuki, Debananda Das, Satoru Kohgo, et al.. (2018). The High Genetic Barrier of EFdA/MK-8591 Stems from Strong Interactions with the Active Site of Drug-Resistant HIV-1 Reverse Transcriptase. Cell chemical biology. 25(10). 1268–1278.e3. 22 indexed citations

10.

Hayashi, Hironori, Nobutoki Takamune, Takashi Nirasawa, et al.. (2014). Dimerization of HIV-1 protease occurs through two steps relating to the mechanism of protease dimerization inhibition by darunavir. Proceedings of the National Academy of Sciences. 111(33). 12234–12239. 57 indexed citations

11.

Maeda, Kenji, Debananda Das, Hirotomo Nakata, & Hiroaki Mitsuya. (2012). CCR5 inhibitors: emergence, success, and challenges. Expert Opinion on Emerging Drugs. 17(2). 135–145. 38 indexed citations

12.

Aoki, Manabu, Matthew Danish, Masayuki Amano, et al.. (2012). Loss of the Protease Dimerization Inhibition Activity of Tipranavir (TPV) and Its Association with the Acquisition of Resistance to TPV by HIV-1. Journal of Virology. 86(24). 13384–13396. 22 indexed citations

13.

Mitsuya, Hiroaki, Kenji Maeda, Debananda Das, & Arun K. Ghosh. (2008). Development of Protease Inhibitors and the Fight with Drug‐Resistant HIV‐1 Variants. Advances in pharmacology. 56. 169–197. 39 indexed citations

14.

Maeda, Kenji, Debananda Das, Philip D. Yin, et al.. (2008). Involvement of the Second Extracellular Loop and Transmembrane Residues of CCR5 in Inhibitor Binding and HIV-1 Fusion: Insights into the Mechanism of Allosteric Inhibition. Journal of Molecular Biology. 381(4). 956–974. 51 indexed citations

15.

Koh, Yasuhiro, Shintaro Matsumi, Debananda Das, et al.. (2007). Potent Inhibition of HIV-1 Replication by Novel Non-peptidyl Small Molecule Inhibitors of Protease Dimerization. Journal of Biological Chemistry. 282(39). 28709–28720. 107 indexed citations

16.

Maeda, Kenji, Debananda Das, Hirotomo Nakata, et al.. (2006). Structural and Molecular Interactions of CCR5 Inhibitors with CCR5. Journal of Biological Chemistry. 281(18). 12688–12698. 130 indexed citations

17.

Das, Debananda, et al.. (2006). Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance. Cellular and Molecular Life Sciences. 63(15). 1706–1724. 41 indexed citations

18.

Gatanaga, Hiroyuki, Debananda Das, Yasuhiro Suzuki, et al.. (2005). Altered HIV-1 Gag Protein Interactions with Cyclophilin A (CypA) on the Acquisition of H219Q and H219P Substitutions in the CypA Binding Loop. Journal of Biological Chemistry. 281(2). 1241–1250. 43 indexed citations

19.

Das, Debananda & Scott L. Whittenburg. (1999). Ab Initio and Density Functional Theory Study of the Geometric Structure, Vibrational Frequency, Torsional Potential, and Isomerization of Dichlorodisulfane (ClSSCl). The Journal of Physical Chemistry A. 103(13). 2134–2140. 12 indexed citations

20.

Das, Debananda & Scott L. Whittenburg. (1999). Performance of the hybrid density functionals in the determination of the geometric structure, vibrational frequency and singlet–triplet energy separation of CH2, CHF, CF2, CCl2 and CBr2. Journal of Molecular Structure THEOCHEM. 492(1-3). 175–186. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact